Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

[Public health surveillance: a pressing need].

Noguer I, Alonso JP, Arteagoitia JM, Astray J, Cano R, de Pedro J, Gutiérrez G, Hervada X, Margolles M, Nicolau A, Núñez D, Pollán M, Ramos JM, Sierra MJ, Vanoclocha H.

Gac Sanit. 2017 Jul - Aug;31(4):283-285. doi: 10.1016/j.gaceta.2016.11.002. Epub 2017 Feb 8. Spanish. No abstract available.

2.

Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).

Piniés JA, González-Carril F, Arteagoitia JM, Irigoien I, Altzibar JM, Rodriguez-Murua JL, Echevarriarteun L; Sentinel Practice Network of the Basque Country.

Diabetologia. 2014 Nov;57(11):2324-33. doi: 10.1007/s00125-014-3370-1. Epub 2014 Sep 12.

PMID:
25212259
3.

Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.

Savulescu C, Jiménez-Jorge S, Delgado-Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A; Spanish Influenza Surveillance System.

Vaccine. 2014 Jul 31;32(35):4404-11. doi: 10.1016/j.vaccine.2014.06.063. Epub 2014 Jun 23.

PMID:
24968153
4.

Dose-response association of physical activity with acute myocardial infarction: do amount and intensity matter?

Elosua R, Redondo A, Segura A, Fiol M, Aldasoro E, Vega G, Forteza J, Martí H, Arteagoitia JM, Marrugat J.

Prev Med. 2013 Nov;57(5):567-72. doi: 10.1016/j.ypmed.2013.07.022. Epub 2013 Aug 14.

PMID:
23954185
5.

Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt-Jakob disease: a case report.

Rodríguez-Martínez AB, López de Munain A, Ferrer I, Zarranz JJ, Atarés B, Villagra NT, Arteagoitia JM, Garrido JM, Juste RA.

J Med Case Rep. 2012 Oct 11;6:348. doi: 10.1186/1752-1947-6-348.

6.

Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.

Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, Larrauri A; cycEVA Study Team; Spanish Influenza Sentinel Surveillance System.

Vaccine. 2012 May 21;30(24):3595-602. doi: 10.1016/j.vaccine.2012.03.048. Epub 2012 Mar 31.

PMID:
22472792
7.

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.

Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, Galmés A, Vanrell JM, Rodriguez C, Vega T, Martinez A, Torner N, Ramos JM, Serrano MC, Castilla J, Cenoz MG, Altzibar JM, Arteagoitia JM, Quiñones C, Perucha M, Larrauri A.

BMC Public Health. 2011 Nov 30;11:899. doi: 10.1186/1471-2458-11-899.

8.

Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in Spain.

Ledesma J, Pozo F, Reina G, Blasco M, Rodríguez G, Montes M, López-Miragaya I, Salvador C, Reina J, Ortíz de Lejarazu R, Egido P, López Barba J, Delgado C, Cuevas MT, Casas I; Spanish Influenza Surveillance System (SISS).

J Clin Virol. 2012 Jan;53(1):16-21. doi: 10.1016/j.jcv.2011.09.032. Epub 2011 Nov 8.

PMID:
22071031
9.

Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.

Ledesma J, Vicente D, Pozo F, Cilla G, Castro SP, Fernández JS, Ruiz MP, Navarro JM, Galán JC, Fernández M, Reina J, Larrauri A, Cuevas MT, Casas I, Breña PP; Spanish Influenza Surveillance System (SISS).

J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.

PMID:
21592854
10.

Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study.

Savulescu C, Jiménez-Jorge S, de Mateo S, Ledesma J, Pozo F, Casas I, Larrauri A; cycEVA Study Team.

Euro Surveill. 2011 Mar 17;16(11). pii: 19820.

11.

Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain.

Ledesma J, Pozo F, Pérez Ruiz M, Navarro JM, Piñeiro L, Montes M, Pérez Castro S, Suárez Fernández J, García Costa J, Fernández M, Galán JC, Cuevas MT, Casas I, Pérez Breña P; Spanish Influenza Surveillance System (SISS).

J Clin Virol. 2011 May;51(1):75-8. doi: 10.1016/j.jcv.2011.01.020. Epub 2011 Feb 24.

PMID:
21353628
12.

A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.

Rodríguez-Martínez AB, Garrido JM, Zarranz JJ, Arteagoitia JM, de Pancorbo MM, Atarés B, Bilbao MJ, Ferrer I, Juste RA.

BMC Neurol. 2010 Oct 25;10:99. doi: 10.1186/1471-2377-10-99.

13.

Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain.

Savulescu C, Valenciano M, de Mateo S, Larrauri A; cycEVA Study Team.

Vaccine. 2010 Apr 1;28(16):2903-7. doi: 10.1016/j.vaccine.2010.01.054. Epub 2010 Feb 11.

PMID:
20153351
14.

Measles risk groups in Spain: implications for the European measles-elimination target.

Peña-Rey I, Martínez de Aragón V, Mosquera M, de Ory F, Echevarría JE; Measles Elimination Plan Working Group in Spain.

Vaccine. 2009 Jun 19;27(30):3927-34. doi: 10.1016/j.vaccine.2009.04.024. Epub 2009 May 3. Review.

PMID:
19376180
15.

Smoking and myocardial infarction case-fatality: hospital and population approach.

Elosua R, Vega G, Rohlfs I, Aldasoro E, Navarro C, Cabades A, Demissie S, Segura A, Fiol M, Moreno-Iribas C, Echanove I, Tormo MJ, Arteagoitia JM, Sala J, Marrugat J; IBERICA investigators.

Eur J Cardiovasc Prev Rehabil. 2007 Aug;14(4):561-7.

PMID:
17667648
16.

[Gender differences in early reperfusion treatment after myocardial infarction].

Aldasoro E, Calvo M, Esnaola S, Hurtado de Saracho I, Alonso E, Audicana C, Arós F, Lekuona I, Arteagoitia JM, Basterretxea M, Marrugat J; IBERICA-País Vasco Group.

Med Clin (Barc). 2007 Jan 27;128(3):81-5. Spanish.

PMID:
17288920
17.

Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.

Larrañaga I, Arteagoitia JM, Rodriguez JL, Gonzalez F, Esnaola S, Piniés JA; Sentinel Practice Network of the Basque Country.

Diabet Med. 2005 Aug;22(8):1047-53.

PMID:
16026371
18.

[Analysis with the propensity score of the association between likelihood of treatment and event of interest in observational studies. An example with myocardial reperfusion].

Martí H, Pérez-Bárcena J, Fiol M, Marrugat J, Navarro C, Aldasoro E, Cabadés A, Segura A, Masiá R, Turumbay J, Cirera L, Arteagoitia JM, Tomás CA, Vega G, Sala J, de Los Arcos E, Tormo MJ, Hurtado-de-Saracho I, Francés-Sempere M, Elosua R; Investigadores del estudio IBERICA.

Rev Esp Cardiol. 2005 Feb;58(2):126-36. Spanish.

19.

Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998.

Marrugat J, Elosua R, Aldasoro E, Tormo MJ, Vanaclocha H, Segura A, Fiol M, Moreno-Iribas C, Pérez G, Arteagoitia JM, Cirera L, Cabadés A, Vega G, Ayestarán JI, García V, Hurtado-de-Saracho I, García J, Zurriaga O, Muñiz J, Sala J; Investigación Búsqueda Especifica y Registro de; Isquemia Coronaria Aguda Investigators.

Eur J Epidemiol. 2004;19(9):831-9.

PMID:
15499893
20.

Familial prion diseases in the Basque Country (Spain).

Zarranz JJ, Digon A, Atarés B, Arteagoitia JM, Carrera N, Fernández-Manchola I, Fernández-Martínez M, Fernández-Maiztegui C, Forcadas I, Galdos L, Ibáñez A, Lezcano E, Martí-Massó JF, Mendibe MM, Urtasun M, Uterga JM, Saracibar N, Velasco F, González de Galdeano L.

Neuroepidemiology. 2005;24(1-2):103-9. Epub 2004 Sep 24.

PMID:
15459517

Supplemental Content

Loading ...
Support Center